Cargando…
O064. Antiepileptic drugs in migraine and epilepsy disorders: who is at increased risk of adverse events?
Autores principales: | Romoli, Michele, Siliquini, Sabrina, Corbelli, Ilenia, Caproni, Stefano, Bedetti, Chiara, Bernetti, Laura, Brahimi, Elona, Costa, Cinzia, Sarchielli, Paola, Calabresi, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715167/ https://www.ncbi.nlm.nih.gov/pubmed/28132319 http://dx.doi.org/10.1186/1129-2377-16-S1-A69 |
Ejemplares similares
-
P066. Migraine with aura in the locker room: 4 case reports
por: Bernetti, Laura, et al.
Publicado: (2015) -
Stopping Onabotulinum Treatment after the First Two Cycles Might Not Be Justified: Results of a Real-life Monocentric Prospective Study in Chronic Migraine
por: Sarchielli, Paola, et al.
Publicado: (2017) -
Migraine with aura in the locker room: three case reports
por: Corbelli, Ilenia, et al.
Publicado: (2011) -
Migraine and epilepsy: what value today?
por: Costa, Cinzia, et al.
Publicado: (2015) -
Migraine-specific quality of life questionnaire and relapse of medication overuse headache
por: Caproni, Stefano, et al.
Publicado: (2015)